DoW Bone Marrow Failure, Investigator-Initiated Research Award
Defense Health Agency Contracting Activity - DHACA
Want a reminder before this closes?
We'll email you 3 days before the deadline. One email, then we stop.
Free. Verify your email, then we send one reminder only.
- Posted
- Jun 17, 2026
- Amount
- Program total $1.3M
- Closes
- Nov 4, 2026
Similar opportunities open now
- DoW Parkinson’s, Investigator-Initiated Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses Nov 6, 2026
- DoW Bone Marrow Failure, Idea Development AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses Nov 4, 2026
- DoW Parkinson’s, Early Investigator Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses Nov 6, 2026
- DoW Rare Cancers Idea Development AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses Nov 18, 2026 (in 17 days)
- DoW Bone Marrow Failure, Resource Development AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses Nov 4, 2026
Classification and identifiers
- Solicitation number
- HT942526BMFRPIIRA
- Assistance listing (CFDA)
- 12.420
Amount
Program total $1.3M
Who can apply
About this opportunity
Summary: Supports studies that further develop mature ideas, expand upon key discoveries, and have the potential to make significant advances in bone marrow (BMF) failure research and/or patient care. Investigator-Initiated Research Award (IIRA) applications may involve translational and clinical research including studies in preclinical models, research with human data and/or anatomical substances, and research with human subjects, as well as correlative studies associated with a clinical trial(s); however, this award mechanism does not support clinical trials. IIRA applications may also support Investigational New Drug (IND)-enabling efforts such as lead compound characterization, and assessments of formulation and stability, absorption, distribution, metabolism and excretion, dose/respo...